Last reviewed · How we verify
Lactosa (placebo arm)
Lactose is an inert sugar used as a placebo control in clinical trials and has no active pharmacological mechanism.
Lactose is an inert sugar used as a placebo control in clinical trials and has no active pharmacological mechanism. Used for Placebo control arm in clinical trials.
At a glance
| Generic name | Lactosa (placebo arm) |
|---|---|
| Also known as | Lactosa |
| Sponsor | Fundació Sant Joan de Déu |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Lactose is a disaccharide carbohydrate that serves as an inactive comparator in clinical studies. It is used in placebo arms to provide a control group for assessing the efficacy and safety of investigational drugs. Lactose itself has no therapeutic mechanism of action relevant to any disease state.
Approved indications
- Placebo control arm in clinical trials
Common side effects
Key clinical trials
- Simvastatin in the Prevention of Recurrent Pancreatitis (PHASE3)
- Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lactosa (placebo arm) CI brief — competitive landscape report
- Lactosa (placebo arm) updates RSS · CI watch RSS
- Fundació Sant Joan de Déu portfolio CI